Amygdala Neurosciences Acquires GS-6637 from Gilead Sciences

PALO ALTO, Calif., Feb 16, 2017 /PRNewswire/ — Amygdala Neurosciences Inc., a biopharmaceutical company focused on the development andĀ …

Link to Full Article

Powered by WPeMatico

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!